3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Unknown
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Plasma cell
1
Other hematologic neoplasm
1
Myeloid
1
Conditions
Lymphoma
10
Breast Neoplasms
10
Leukemia
9
Carcinoma, Ovarian Epithelial
8
Ovarian Neoplasms
7
Multiple Myeloma
7
Prostatic Neoplasms
6
Precursor Cell Lymphoblastic Leukemia-Lymphoma
6
Neuroblastoma
6
Myelodysplastic Syndromes
6
Melanoma
6
Lymphoma, Non-Hodgkin
6
Lymphoma, Mantle-Cell
6
Lymphoma, Large B-Cell, Diffuse
6
Leukemia, Myeloid, Acute
6
Leukemia, Lymphocytic, Chronic, B-Cell
6
Glioblastoma
6
Carcinoma, Non-Small-Cell Lung
6
Astrocytoma
6
Lymphoma, Follicular
5
Lung Neoplasms
5
Brain Neoplasms
5
Oligodendroglioma
4
Neoplasms, Plasma Cell
4
Lymphoma, Large-Cell, Immunoblastic
4
Lymphoma, B-Cell, Marginal Zone
4
Leukemia, Myelomonocytic, Chronic
4
Leukemia, Myeloid, Chronic-Phase
4
Leukemia, Myeloid, Accelerated Phase
4
Hodgkin Disease
4
Interventions
Lenalidomide
3
PVX-410 vaccine
2
siltuximab
1
sargramostim
1
poly ICLC
1
dexamethasone acetate
1
dexamethasone 21-phosphate
1
citarinostat
1
auricularum
1
atezolizumab
1
Receptors, Interleukin-6
1
Monatide (IMS 3015)
1
Interleukin 1 Receptor Antagonist Protein
1
Emulsions
1
Dexamethasone
1
Calcium Dobesilate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 1
×
Smoldering Multiple Myeloma
×
sargramostim
×
Clear all
NCT02240537
2016-04-19
BBMPI03
Benovus Bio, Inc.
Phase 1
Unknown
4 enrolled